Rockwell Medical (RMTI)
(Delayed Data from NSDQ)
$4.02 USD
+0.08 (2.03%)
Updated Sep 18, 2024 04:00 PM ET
After-Market: $4.03 +0.01 (0.25%) 7:58 PM ET
1-Strong Buy of 5 1
C Value A Growth C Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$4.02 USD
+0.08 (2.03%)
Updated Sep 18, 2024 04:00 PM ET
After-Market: $4.03 +0.01 (0.25%) 7:58 PM ET
1-Strong Buy of 5 1
C Value A Growth C Momentum A VGM
Zacks News
Rockwell Medical Stock Surges 108.5% YTD: Should You Snap it Up Now?
by Urmimala Biswas
RMTI continues to outperform its peers, banking on its focus on optimizing business to drive sustainable profitability and meaningful cash flow generation.
Rockwell Medical (RMTI) is a Great Momentum Stock: Should You Buy?
by Zacks Equity Research
Does Rockwell Medical (RMTI) have what it takes to be a top stock pick for momentum investors? Let's find out.
Why Fast-paced Mover Rockwell Medical (RMTI) Is a Great Choice for Value Investors
by Zacks Equity Research
If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, Rockwell Medical (RMTI) could be a great choice. It is one of the several stocks that passed through our 'Fast-Paced Momentum at a Bargain' screen.
Rockwell Medical, Inc. (RMTI) Hit a 52 Week High, Can the Run Continue?
by Zacks Equity Research
Rockwell Medical (RMTI) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Rockwell Medical, Inc. (RMTI) Hits Fresh High: Is There Still Room to Run?
by Zacks Equity Research
Rockwell Medical (RMTI) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Fast-paced Momentum Stock Rockwell Medical (RMTI) Is Still Trading at a Bargain
by Zacks Equity Research
If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, Rockwell Medical (RMTI) could be a great choice. It is one of the several stocks that passed through our 'Fast-Paced Momentum at a Bargain' screen.
Rockwell Medical (RMTI) Tops Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Rockwell Medical (RMTI) delivered earnings and revenue surprises of 125% and 12.26%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Jushi Holdings Inc. (JUSHF) Reports Q2 Loss, Lags Revenue Estimates
by Zacks Equity Research
Jushi Holdings Inc. (JUSHF) delivered earnings and revenue surprises of 83.33% and 3.81%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
TG Therapeutics (TGTX) Surpasses Q2 Earnings and Revenue Estimates
by Zacks Equity Research
TG Therapeutics (TGTX) delivered earnings and revenue surprises of 200% and 11.12%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Evolus, Inc. (EOLS) Reports Q2 Loss, Tops Revenue Estimates
by Zacks Equity Research
Evolus (EOLS) delivered earnings and revenue surprises of -75% and 2.85%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Rockwell Medical (RMTI) Reports Q1 Loss, Tops Revenue Estimates
by Zacks Equity Research
Rockwell Medical (RMTI) delivered earnings and revenue surprises of 60% and 7.06%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
InMode (INMD) Q1 Earnings and Revenues Beat Estimates
by Zacks Equity Research
InMode (INMD) delivered earnings and revenue surprises of 12.50% and 0.23%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Rockwell Medical (RMTI) Increases Despite Market Slip: Here's What You Need to Know
by Zacks Equity Research
In the latest trading session, Rockwell Medical (RMTI) closed at $1.65, marking a +1.85% move from the previous day.
Rockwell Medical (RMTI) Q4 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Rockwell Medical (RMTI) delivered earnings and revenue surprises of 125% and 0.01%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
Rockwell Medical (RMTI) Rises As Market Takes a Dip: Key Facts
by Zacks Equity Research
Rockwell Medical (RMTI) concluded the recent trading session at $1.54, signifying a +1.32% move from its prior day's close.
Rockwell Medical (RMTI) Ascends While Market Falls: Some Facts to Note
by Zacks Equity Research
In the closing of the recent trading day, Rockwell Medical (RMTI) stood at $1.48, denoting a +0.68% change from the preceding trading day.
Rockwell Medical (RMTI) Flat As Market Gains: What You Should Know
by Zacks Equity Research
In the closing of the recent trading day, Rockwell Medical (RMTI) stood at $1.37, denoting no change from the preceding trading day.
Why Rockwell Medical (RMTI) Dipped More Than Broader Market Today
by Zacks Equity Research
In the closing of the recent trading day, Rockwell Medical (RMTI) stood at $1.34, denoting a -0.74% change from the preceding trading day.
Rockwell Medical (RMTI) Flat As Market Gains: What You Should Know
by Zacks Equity Research
Rockwell Medical (RMTI) closed at $1.29 in the latest trading session, marking no change from the prior day.
Rockwell Medical (RMTI) Reports Q3 Loss, Tops Revenue Estimates
by Zacks Equity Research
Rockwell Medical (RMTI) delivered earnings and revenue surprises of 41.67% and 0.43%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?
Why Rockwell Medical (RMTI) Outpaced the Stock Market Today
by Zacks Equity Research
Rockwell Medical (RMTI) closed the most recent trading day at $1.95, moving +1.04% from the previous trading session.
Rockwell Medical (RMTI) Suffers a Larger Drop Than the General Market: Key Insights
by Zacks Equity Research
The latest trading day saw Rockwell Medical (RMTI) settling at $1.58, representing a -1.25% change from its previous close.
Rockwell Medical (RMTI) Stock Moves -1.18%: What You Should Know
by Zacks Equity Research
Rockwell Medical (RMTI) closed at $1.68 in the latest trading session, marking a -1.18% move from the prior day.
Why Rockwell Medical (RMTI) Dipped More Than Broader Market Today
by Zacks Equity Research
The latest trading day saw Rockwell Medical (RMTI) settling at $1.97, representing a -0.51% change from its previous close.
Rockwell Medical (RMTI) Gains As Market Dips: What You Should Know
by Zacks Equity Research
Rockwell Medical (RMTI) closed at $2.06 in the latest trading session, marking a +1.48% move from the prior day.